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Exome Sequencing Identifies Mutations in CCDC114
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Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary
disease and situs abnormalities. PCD-causing mutations have been identified in 14 genes, but they collectively account for only
~60% of all PCD. To identify mutations that cause PCD, we performed exome sequencing on six unrelated probands with ciliary outer
dynein arm (ODA) defects. Mutations in CCDC114, an ortholog of the Chlamydomonas reinhardtii motility gene DCC2, were identified
in a family with two affected siblings. Sanger sequencing of 67 additional individuals with PCD with ODA defects from 58 families
revealed CCDC114 mutations in 4 individuals in 3 families. All 6 individuals with CCDC114 mutations had characteristic oto-sino-
pulmonary disease, but none had situs abnormalities. In the remaining 5 individuals with PCD who underwent exome sequencing,
we identified mutations in two genes (DNAI2, DNAH5) known to cause PCD, including an Ashkenazi Jewish founder mutation in
DNAI2. These results revealed that mutations in CCDC114 are a cause of ciliary dysmotility and PCD and further demonstrate the utility
of exome sequencing to identify genetic causes in heterogeneous recessive disorders.Primary ciliary dyskinesia (PCD) is a rare, autosomal-
recessive disorder (MIM 244400) of motile cilia structure
and/or function (incidence, ~1:16,000). Clinical features
include respiratory distress in term neonates, onset of
chronic cough and middle ear disease early in life, chronic
rhinosinusitis, age-dependent bronchiectasis, defective
sperm motility/infertility in males, and laterality defects
in 50% of affected individuals (see References1–5 and
GeneReviews in Web Resources). The diagnosis of PCD
has traditionally relied on transmission electron micros-
copy (EM) to demonstrate different types of ultrastructural
defects in cilia (for example, outer and/or inner dynein
arm defects and/or central apparatus defects) as we and
others have reported (see References2–10 and GeneReviews
in Web Resources).
PCD is highly genetically heterogeneous, and mutations
in 14 known genes collectively account for just ~60% of
cases. Interestingly, mutations of each known gene are
linked to a specific ciliary ultrastructural phenotype (re-
viewed in GeneReviews, Zariwala et al.,2 Chilvers et al.11).
We speculated that studying individuals with the same
ciliary phenotype (ultrastructural defect) would facilitate
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The Amelying PCD; therefore, we performed exome sequencing
of six unrelated individuals with isolated outer dynein
arms (ODA) defects, which is the most common ciliary
phenotype in PCD (see References2,6–10 and GeneReviews
inWeb Resources). Clinical, phenotypic, and demographic
information of these six individuals, including levels of
nasal nitric oxide (nNO), which are very low
in PCD,3,5,9,12 are presented (Table 1 and Table S1 avail-
able online). To enhance the likelihood of identifying
mutations in additional gene(s), we selected for exome
sequencing only those individuals in whom mutations
in the two genes (DNAH5 [MIM 603335]; DNAI1
[MIM 604366]) most frequently associated with ODA
defects (see References2,13–15 and GeneReviews in Web
Resources) had been excluded by Sanger sequencing.
The study was approved by the Committee for the
Protection of the Rights of Human Subjects at the UNC
and participating institutions, and written consent was
obtained.
Exome sequencing was performed as previously
described.16 The Nimblegen EZ SeqCap kit (Roche) was
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Table 1. Demographic, Clinical, and CCDC114 Mutations in Six PCD-Affected Individuals from Four Unrelated Families
Individual # Family # Sex
Age in
Years
Situs
Status
Ciliary
Ultra-
structural
Defect Ethnicity
nNO
nl/mina
Neo
RDS Bxsis Sinusitis
Otitis
Media
Allele 1 Allele 2
Exon/
Intron
Base
Change
Amino Acid
Change
Segre-
gationb
Exon/
Intron
Base
Change
Amino Acid
Change
Segre-
gationb
Homozygous Mutations
#359c UNC-62 F 39 SS ODA white 36.0 yes yes yes yes Ex 7 c.742G>Ad p.Ala248Serfs*52 paternalc Ex 7 c.742G>Ad p.Ala248Serfs*52 maternal
#360c UNC-62 F 33 SS ODA white 31.5 yes yes yes yes Ex 7 c.742G>Ad p.Ala248Serfs*52 paternalc Ex 7 c.742G>Ad p.Ala248Serfs*52 maternal
Compound Heterozygous Mutations
#891 UNC-139 F 59 SS ODA white 32.4 yes yes yes yes Ex 7 c.742G>Ad p.Ala248Serfs*52 NAe Int 5 c.4872A>Gd p.Glu163Glyfs*60,
p.Glu163_
Val184delinsg
NAe
#897 UNC-140 M 3 SS ODA white 9.6 yes no no yes Ex 7 c.742G>Ad p.Ala248Serfs*52 maternal Int 12 c.1391þ5G>Ad p.Ser432Argfs*7 paternal
#1107 UNC-212 F 34 SS ODA white 5.5 no yes yes yes Ex 7 c.742G>Ad p.Ala248Serfs*52 maternalf Ex 9 c.939delT p.His313Glnfs*14 paternal
#1114 UNC-212 F 38 SS NA white NA no NA NA yes Ex 7 c.742G>Ad p.Ala248Serfs*52 maternalf Ex 9 c.939delT p.His313Glnfs*14 paternal
Abbreviations: M, male; F, female; SI, situs inversus; SA, situs ambiguous; SS, situs solitus; NA, not available; ODA, outer dynein arms; Neo RDS, neonatal respiratory distress in full-term birth; Bxsis, bronchiectasis; nNO, nasal
nitric oxide.
aNormal nNO levels are 376 5 124 nl/min (mean 5 SD), calculated from 27 healthy subjects.3
bMutant allele shown to segregate with either the father’s (paternal) or mother’s (maternal) side of the family.
cDNA from father was not available, but paternal aunt carried the mutation and hence father was an obligate carrier, see details in Figure 1 showing segregation analysis.
dSplice-site mutations interrogated with RT-PCR, see details in Table 2.
eThree unaffected siblings of the affected individual, each carried only one mutation representing trans inheritance, see details in Figure 1 showing segregation analysis.
fDNA from father was not available, but mother carried the other mutation so father is an obligate carrier, see details in Figure 1 showing segregation analysis.
gTwo transcripts were observed predicting two different translation products.
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Figure 1. Cross-section Analysis of Ciliary Ultrastructure by Electron Microscopy and Segregation Analysis of CCDC114
(A) Normal ciliary ultrastructure from healthy subject (left) and absence of outer dynein arms (right) from UNC family 62 with biallelic
mutations in CCDC114.
(B–E) Pedigrees with mutations segregating in trans, consistent with autosomal-recessive mode of inheritance.an 8 base pair barcode, followed by PCR amplification.
Libraries were hybridized to EZSeqCap V1 (corresponding
to CCDS2008 gene set) solution-based probe, amplified,
pooled, and sequenced on Illumina GAIIx (PE76þ barcode
read). The final targeted region was 26,402,573 bp that
included 16,151 genes (198,334 exons and splice junc-
tions). The average mean fold coverage was 843; ~98%
target bases were covered at least at 13 and ~93% covered
at 83. The details of capture statistics and coverage are
presented in Table S2. After barcode-based sample decon-
volution, sequence reads were mapped with BWA tools to
the human genome (hg18). Sequence variant calls were
performed by SAMtools after removing potential PCR
duplicates, with a minimum quality threshold of 30 for
SNPs and 200 for indels. On average we called 18,235
base substitutions and 578 insertions/deletions per indi-
vidual (Table S2). Genotypes were annotated with the
SeattleSeq server (Table S3). Missense-, nonsense-, or
splice-site-altering variants absent from 1000 Genomes
data and also absent or at a minor allele frequency (MAF)
of <1% in other exomes sequenced at the University of
Washington (n ¼ 849) were considered further, as were
indels that were absent or observed <10 times in the other
exomes sequenced at the University ofWashington. Under
an autosomal-recessive model for PCD, only genes withThe Amerbiallelic variants (homozygous or compound heterozy-
gous) were considered further (Tables S2 and S3). We
manually checked each of these variants for its potential
of being pathogenic, highlighting a subset for validation
by Sanger sequencing. Candidate genes were prioritized
for validation by Sanger sequencing (Tables S3 and S4),
based on expression in ciliated airway epithelia (RNA-seq
data set, unpublished) and potential relevance to PCD as
assessed through published information, including anal-
ysis of large-scale coexpression data sets.17,18 The primer
sequences and results of validation are depicted in Tables
S3 and S4. For the potentially pathogenic variants in a
proband, segregation analysis on the available DNA from
the relatives was carried out.
An apparently homozygous missense variant
(c.742G>A) was identified in CCDC114 (RefSeq: NM_
144577.3) at the last base of exon 7 in an individual with
PCD with ODA defect (Figure 1A), altering the protein
sequence and potentially affecting splicing. Sanger
sequencing confirmed inheritance in trans for the propos-
itus and an affected sibling, and two unaffected siblings
had no mutation (Figure 1B). The CCDC114 ortholog
in Chlamydomonas reinhardtii, DCC2 (oda-DC2),19 encodes
a component of the outer dynein arm docking complex,
and a Chlamydomonas mutant in DCC2 (oda1.1) hasican Journal of Human Genetics 92, 99–106, January 10, 2013 101
Figure 2. Genomic Organization of CCDC114 and Location of PCD-Causing Mutations
(A) The transcript ofCCDC114 consists of 3,215 bp and encodes 670 amino acid protein. Filled box designates exons ‘‘E,’’ horizontal lines
designate intron ‘‘IVS,’’ and location of 50 UTR, 30 UTR, and start and stop codons are shown. Introns/exons are not drawn to scale. The
positions of all identified CCDC114 mutations are indicated.
(B, D, and E) Heterozygous sequences in affected (bottom) and corresponding wild-type (top) sequences in controls.
(C) Homozygous (bottom) and heterozygous (middle) sequences in affected and the corresponding wild-type sequences (top) in control.
Base sequence, amino acid sequence, and codon numbers are shown. Intron-exon junctions are shown with the red dotted lines.impaired motility and ODA defects analogous to the
ultrastructural defect in PCD. Therefore, we performed
high-throughput Sanger-based sequencing of CCDC114
(Genotyping and Resequencing Services in Seattle; RC2-
HL-102923; MJB-primer sequences: Table S5) in 104 addi-
tional individuals with PCD from 91 families (67 affected
individuals from 58 families with isolated ODA defects; 37
affected individuals from 33 families with ODAþIDA
defects) (Table S6). Four individuals from three families
with isolated ODA defects had biallelic mutations in
CCDC114, including two affected siblings (UNC family
212) (Table 1). Segregation analysis at UNC by Sanger
sequencing (capillary electrophoresis; Applied Biosystems,
Foster City, CA) confirmed that the mutations were in-
herited in trans (Table 1, Figures 1C–1E). In total, there
were four different mutations (three splice-site and one
frameshift) in four unrelated families.
The c.742G>A splice-site variant was found in each
unrelated PCD family: homozygous in one family and
compound heterozygous in three families harboring102 The American Journal of Human Genetics 92, 99–106, January 10a different splice-site or frameshift mutation on the second
allele (Table 1). The genomic organization of CCDC114
and location of mutations is shown (Figure 2). The finding
that c.742G>A is a rare PCD-causing variant is consistent
with the observation that this splice mutation is present
at very low frequency on the NHBLI Exome Variant Server
(EVS) (3 of 7,020 alleles; 0.043%) in non-PCD subjects of
European ancestry, as compared with our 64 families
with isolated ODA defects (5 of 128 alleles; 3.9%). The
presence of likely causative mutations in EVS indicates
that the depth of publicly available data for genetic varia-
tion is now sufficiently deep that caution must be exer-
cised when filtering exome or genome data, particularly
for recessive disorders. Neither intronic splice mutations
(c.4872A>G, c.1391þ5G>A) nor the frameshift muta-
tion (c.939delT) was present in either dbSNP or EVS. For
subjects harboring the c.742G>A mutation, we con-
structed haplotypes for all variants/polymorphisms in
CCDC114 and found that all affected individuals carried
a conserved haplotype in ciswith the c.742G>Amutation,, 2013
Table 2. Effect of CCDC114 Splice-Site Mutations on cDNA Transcript via Reverse-Transcriptase PCR in Individuals with PCD
Primer Seta
Mutation Intron/
Exon Location
Genomic Mutations
(Predicted Amino
Acid Change)
cDNA Transcript after RT-PCR
(Predicted Amino Acid Change) Comments
exons 4 sense þ
10 antisense
exon 7b c.742G>A
(p.Ala248Thr)
mutant 1: r.742þ1_742þ79ins
(p.Ala248Serfs*52)
Mutant 1 had insertion of 79 bp from
start of intron 7 followed by cryptic
splice donor site and addition of exon 8.
Wild-type amplification product: 657 bp.
Mutant amplification product: 736 bp.
mutant 2: r.554þ1_554þ98ins;
742þ1_742þ79ins (p.Glu186*)
Mutant 2 had insertion of 98 bp from
start of intron 6 followed by cryptic
splice donor site and addition of exon 7,
as well as insertion of 79 bp from start
of intron 7 followed by cryptic splice
donor site and addition of exon 8.
Wild-type amplification product: 657 bp.
Mutant amplification product: 834 bp.
exons 10 sense þ
13 antisense
exon 7c c.742G>A
(p.Ala248Thr)
mutant: r.1129þ1283_1129þ1410ins Mutant had insertion of 128 bp from
the middle of intron 10 due to cryptic
splice donor and acceptor sites following
exon 10. The mutant transcript was
in cis with T allele for c.1403C>T
(p.Pro468Leu) polymorphism; proxy
for c.742G>A mutation indicating
transcript was caused by this mutation.
Wild-type amplification product: 479 bp.
Mutant amplification product: 607 bp.
exons 4 sense þ
10 antisense
intron 5d c.4872A>G
(g.IVS52A>G)
mutant 1: r.487_554del
(p.Glu163Glyfs*60)
Mutant 1 had deletion of all 68 bp
of exon 6 followed by joining of
exons 5 and 7. Wild-type amplification
product: 657 bp. Mutant amplification
product: 589 bp.
mutant 2: r.4871_48759ins;
487_554del (p.Glu163_Val184delins)
Mutant 2 had insertion of 59 bp from
the end of intron 6 as well as deletion
of all 68 bp of exon 6 leading to
in-frame deletion of 22 amino acids
that are replaced by insertion of 19
mutant amino acids. Wild-type
amplification product: 657 bp.
Mutant amplification product: 648 bp.
exons 10 sense þ
13 antisense
intron 12 c.1391þ5G>A
(g.IVS12þ5G>A)
mutant: r.1294_1391del
(p.Ser432Argfs*7)
Out-of-frame deletion of exon 12
leading to premature translation
termination signal. Wild-type
amplification product: 479 bp.
Mutant amplification product: 381 bp.
aPrimer sequences depicted in Table S8. RT-PCR was carried out on ciliated epithelia cells collected from inferior nasal turbinate as shown previously.14
bTwo mutant transcripts, both causing frameshift leading to premature translation termination signal, were identified for c.742G>A mutation that is located on
the last base in exon 7 on conserved splice donor site in UNC-139 (#891) (I-3 in Figure 1C) as depicted in Figure S2. Only mutant transcript 1 was identified in both
siblings in UNC-62 who carried homozygous c.742G>A mutation.
cAmplification with primer set exons 4 sense þ 13 antisense in individuals with homozygous c.742G>A mutation yielded two major products probably represent-
ing the inclusion of intron 75 the inclusion of intron 10. Analysis of other individuals by RT-PCR and agarose gel electrophoresis (data not shown) indicated the
presence of mutant transcripts with insertion of part of intron 10 in all affected individuals carrying c.742G>A mutation. Irrespective of whether all mutant tran-
scripts resulting from c.742G>Amutations occur with insertion of parts of introns 6, and/or 7, and/or 10, they all cause frameshift leading to premature translation
termination signal.
dTwo mutant transcripts were identified for g.IVS52A>Gmutation in UNC-139 (#891) (I-3 in Figure 1C) as depicted in Figure S4. This individual had c.742G>A
mutation on the trans allele, but both mutant transcripts were wild-type at c.742G>A locus, indicating that both these transcripts are caused by g.IVS52A>G
mutation.compatible with being a founder mutation (Figure S1).
Multiple benign variants are listed that were identified in
CCDC114 (Table S7).
To determine the effect of splice variants in CCDC114,
reverse-transcriptase polymerase chain reaction (RT-PCR)
was performed on RNA from nasal epithelia of individuals
with biallelic mutations with cyclophilin as a control
(primer sequences: Table S8). The exonic splice-site muta-
tion c.742G>A (present on at least one allele in six individ-
uals from four families) yielded two mutant transcripts,The Amerboth resulting in premature translation termination signals
(Table2, Figure S2).Using adifferentdownstreamprimer set
revealed another splicing defect on the samemutant allele,
indicating impairment of splicing distal to themutation, as
well (Table 2, Figure S3). The aberrant splicing that is three
exons downstream from c.742G>A could not compensate
for the upstream frameshift, as the upstream insertions
lead to termination codons before the inclusion of intron
10. The c.4872A>G (g.IVS52A>G) mutation also
yielded two mutant transcripts, one causing prematureican Journal of Human Genetics 92, 99–106, January 10, 2013 103
Figure 3. Expression Analysis via
Reverse-Transcriptase PCR
(A) Expression pattern of CCDC114 in
a panel of normal human tissues.
(B) Expression pattern of CCDC114 (top)
during ciliogenesis in human airway cells.
RNA was isolated from human airway
epithelia cells at different times after
plating on collagen-coated culture inserts
at an air/liquid interface. Under these
conditions the cells initially grow as
a single monolayer of undifferentiated
‘‘basal-like’’ cells. After 10–14 days, ciliated
cells begin to appear, increasing over the next 2–3 weeks before plateauing at approximately 60%–80% of the culture.21,22 For both
expression analyses, DNAI1 (middle) was used as a known ciliary gene control and cyclophilin (bottom) as a positive RNA control.translation termination signals and another causing in-
frame deletion of exon 6 and inclusion of part of intron 6
(Table 2, Figure S4). The intron 12 splice mutation
(c.1391þ5G>A [g.IVS12þ5G>A]) caused an out-of-frame
deletion of exon 12 and a premature translation termina-
tion signal (Table 2, Figure S5).
Although 51 individuals with PCD with situs abnormali-
ties underwent CCDC114 mutation analysis (Table S6),
none had mutations. This suggests that CCDC114 muta-
tions do not affect embryonic nodal cilia motility, and/or
that the splicemutant (c.742G>A) is leaky, renderingpartial
function. Consistent with this, there was faint amplifica-
tionof full-lengthmRNA (confirmedby Sanger sequencing)
in nasal epithelial RNA from an individual (#359, III-1 in
Figure 1B) homozygous for c.742G>A (Figure S6). Despite
this leakiness, clinical features and nasal nitric oxide values
in individuals withCCDC114mutations (Table 1) are indis-
tinguishable from individuals with ‘‘classic’’ PCDwithODA
defects and mutations in DNAI1 and DNAH5.13–15,20
CCDC114 is highly expressed in testis (Figure 3) and males
with PCD are frequently infertile. However, the only male
patient in this study is currently7yearsold,whichprecludes
study of fertility or spermmotility.
Genetic data indicating that CCDC114 mutations reces-
sively cause PCDwas robustly supported by additional bio-
logical studies. (1) CCDC114 shows a similar pattern of
expression (e.g., high in lung and testis) as DNAI1, muta-
tions in which cause PCD with ciliary ODA defects14
(Figure 3A). (2) CCDC114 expression in cultured human
bronchial cells21,22 over 30 days parallels the time course
of ciliary differentiation andDNAI1 expression (Figure 3B).
(3) Quantitative proteomic analysis of isolated human cilia
by data-independent mass spectrometry (LC/MSE)23,24
demonstrate that CCDC114 is present in equimolar
amounts as DNAI1, mutations in which cause PCD. (4)
Videomicroscopy analysis of nasal epithelial cilia obtained
by nasal-scrape biopsy from five individuals with biallelic
mutations in CCDC114 showed complete ciliary immotil-
ity in most ciliated cells and stiff dyskinetic cilia in some
cells.11,25 When activity was sufficient to quantify ciliary
beat frequency, it was reduced compared to normal
(average 3.1 Hz versus 7.35 1.5 [SD] Hz at 25C)25 (Movies
S1, S2, and S3).104 The American Journal of Human Genetics 92, 99–106, January 10The identification of mutations in CCDC114 as PCD
causing is also congruent with other information. (1) The
Chlamydomonas reinhardtiimotility mutant oda1.1 is defec-
tive inDCC2,19 an ortholog ofCCDC114. Interestingly, the
oda1.1mutant displays a reduced beat frequency, but is not
immotile, suggesting that the absence of outer dynein
arms has different functional consequences in these two
organisms (human and Chlamydomonas). (2) There is coor-
dinate regulation between CCDC114 and other known
genes harboring mutations causing PCD (gene expression
data set; UGET).17,18 (3) Three other members of the
coiled-coil domain containing (CCDC) family of genes
(CCDC39 [MIM 613798], CCDC40 [MIM 613799],
CCDC103 [MIM 614677]) are known to play a role in
assembly of ciliary inner dynein arms, dynein regulatory
complexes, and outer dynein arms, andmutations in these
CCDC genes cause PCD.26–29 (4) CCDC114 has never been
associated with any other genetic disorder.
For the five remaining individuals with PCD with ODA
defects who had exome sequencing, three individuals of
Ashkenazi Jewish ethnicity had identical homozygous
nonsense (c.1304G>A [p.Trp453*]) mutations in DNAI2
(MIM 605483; RefSeq: NM_023036.4) that were inherited
in trans (Figure S7). Other mutations in DNAI2 have been
reported as a rare cause of PCD with ODA defects.30 All
three individuals shared a ~158 kb haplotype in cis with
c.1304G>A, indicative of a founder event (Figure S8).
Exome sequencing also identified two mutations in
DNAH5 (RefSeq: NM_001369.2) in an individual with
PCD who previously did not have biallelic mutations iden-
tified by Sanger sequencing. The two mutants were a 1 bp
insertion in exon 16 (c.2261_2262insT [p.Met754Ilefs*5])
and a missense variant (c.6249G>A [p.Met2083Ile]) at
the last base of exon 37. Review of the original Sanger
sequencing primers for exon 16 revealed a rare variant
at the 30 end of the original antisense primer binding
site, thereby causing the allele dropout (Figure S9A).
Both mutations were present in an affected sibling, and
each parent was a carrier (Figures S9B–S9D). RT-PCR
of nasal RNA demonstrated the exon 37 (c.6249G>A)
mutation affected splicing, leading to premature transla-
tion termination signal (Figure S10). This illustrates
that mutations missed by Sanger sequencing may be, 2013
identified by different techniques and that retesting of
exon 16 may be appropriate, if biallelic mutations in
DNAH5 were not identified by Sanger sequencing with
the published primer set.20 In one individual of Asian-
Indian descent with PCD, two missense variants in
DNAH5 were identified by exome sequencing and
confirmed by Sanger sequencing: c.1121T>C (p.Ile374Thr)
in exon 9 and c.3139G>A (p.Gly1047Arg) in exon 20. The
variants were inherited in trans (Figures S11A–S11C), and
the amino acids were well conserved across species
(Figure S11D). In silico mutation prediction analysis
(Mutation Taster)31 scored them as deleterious and both
are very rare in public databases, but further genetic and/
or functional studies will be necessary to confirm the role
of these variants in PCD.
In conclusion, exome sequencing identified mutations
in CCDC114 as a cause of PCD in ~6% of individuals
with PCD and an ODA defect. Additionally, we identified
a nonsensemutation inDNAI2 that appears to be a founder
mutation in individuals with PCD with Ashkenazi Jewish
ethnicity. The identification of genetic causes of PCD in
six families via exome sequencing further demonstrates
the power of this approach for identifying the etiology in
genetically heterogeneous disorders.Supplemental Data
Supplemental Data include 11 figures, 8 tables, and 3 movies and
can be found with this article online at http://www.cell.com/
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